David Veesler

David Veesler is a French biochemist and an assistant professor in the Department of Biochemistry at the University of Washington,^[1] where his group focuses on the study the structural biology of infectious diseases.^[2] His team recently helped determine the structure of the SARS-CoV-2 spike glycoprotein ^[3] using Cryo-EM techniques, and it is currently trying to identify neutralizing antibodies for SARS-CoV-2 that could be used as a preventative treatment against COVID-19 or as a post-exposure therapy^[4] using X-ray crystallography.^[5] Veesler is Howard Hughes Medical Investigators.^[6]

Education

David Veesler earned his Ph.D. from Aix-Marseille University in France in 2010. He was a visiting researcher at the University of Zurich in Switzerland during his PhD, and joined the Scripps Research Institute in La Jolla, California as postdoctoral fellow from 2011 to 2014 before joining the University of Washington.^[7]

Awards and honors

2013 Microscopy Society of America Presidential Scholar Award
2012 The Scripps Research Institute Fall Research Symposium Award
2011 Marie-Curie International Outgoing Postdoctoral Fellowship
2011 French Crystallographic Association PhD award
2009 Wyatt Technology award
2006 French Ministry of Higher Education and Research PhD fellowship

References

^ David Veesler faculty profile, University of Washington
^ Veesler Lab website
^ Walls, Alexandra C.; Park, Young-Jun; Tortorici, M. Alejandra; Wall, Abigail; McGuire, Andrew T.; Veesler, David (2020). "Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein" (PDF). Cell. 181 (2): 281–292.e6. doi:10.1016/j.cell.2020.02.058. PMC 7102599. PMID 32155444.
^ Pinto, Dora; Park, Young-Jun; Beltramello, Martina; Walls, Alexandra C.; Tortorici, M. Alejandra; Bianchi, Siro; Jaconi, Stefano; Culap, Katja; Zatta, Fabrizia; De Marco, Anna; Peter, Alessia; Guarino, Barbara; Spreafico, Roberto; Cameroni, Elisabetta; Case, James Brett; Chen, Rita E.; Havenar-Daughton, Colin; Snell, Gyorgy; Telenti, Amalio; Virgin, Herbert W.; Lanzavecchia, Antonio; Diamond, Michael S.; Fink, Katja; Veesler, David; Corti, Davide (2020). "Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody". Nature. 583 (7815): 290–295. Bibcode:2020Natur.583..290P. doi:10.1038/s41586-020-2349-y. PMC 7255795. PMID 32422645. S2CID 256822613.
^ X-ray Experiments Zero in on COVID-19 Antibodies – Berkeley Lab News Center
^ HHMI Invests $300 Million in 33 New Investigators – HHMI
^ David Veesler – CV, University of Washington

[1] David Veesler faculty profile, University of Washington

[2] Veesler Lab website

[3] Walls, Alexandra C.; Park, Young-Jun; Tortorici, M. Alejandra; Wall, Abigail; McGuire, Andrew T.; Veesler, David (2020). "Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein" (PDF). Cell. 181 (2): 281–292.e6. doi:10.1016/j.cell.2020.02.058. PMC 7102599. PMID 32155444.

[4] Pinto, Dora; Park, Young-Jun; Beltramello, Martina; Walls, Alexandra C.; Tortorici, M. Alejandra; Bianchi, Siro; Jaconi, Stefano; Culap, Katja; Zatta, Fabrizia; De Marco, Anna; Peter, Alessia; Guarino, Barbara; Spreafico, Roberto; Cameroni, Elisabetta; Case, James Brett; Chen, Rita E.; Havenar-Daughton, Colin; Snell, Gyorgy; Telenti, Amalio; Virgin, Herbert W.; Lanzavecchia, Antonio; Diamond, Michael S.; Fink, Katja; Veesler, David; Corti, Davide (2020). "Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody". Nature. 583 (7815): 290–295. Bibcode:2020Natur.583..290P. doi:10.1038/s41586-020-2349-y. PMC 7255795. PMID 32422645. S2CID 256822613.

[5] X-ray Experiments Zero in on COVID-19 Antibodies – Berkeley Lab News Center

[6] HHMI Invests $300 Million in 33 New Investigators – HHMI

[7] David Veesler – CV, University of Washington

[1]

[2]

[3]

[4]

[5]

[6]

[7]